Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0820
+0.0080 (10.81%)
Mar 31, 2025, 4:00 PM EST

Altamira Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Mar '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
01627305
Upgrade
Market Cap Growth
-18.65%-75.59%-78.93%-10.02%459.12%-65.68%
Upgrade
Enterprise Value
15111830-1
Upgrade
Last Close Price
0.083.4897.00726.001048.00648.00
Upgrade
PB Ratio
0.030.21-0.682.071.780.89
Upgrade
P/TBV Ratio
1.470.54--3.91-
Upgrade
Debt / Equity Ratio
0.070.02-0.760.040.03-
Upgrade
Quick Ratio
0.150.780.060.343.740.71
Upgrade
Current Ratio
0.431.380.140.843.831.04
Upgrade
Return on Equity (ROE)
-369.51%--790.08%-44.88%-71.91%-136.94%
Upgrade
Return on Assets (ROA)
-57.04%-52.83%-27.56%-16.70%-21.99%-47.50%
Upgrade
Return on Capital (ROIC)
-99.71%-161.65%-60.38%-21.60%-28.31%-81.59%
Upgrade
Earnings Yield
-703.50%-279.56%-467.82%-63.38%-27.41%-123.96%
Upgrade
FCF Yield
-304.94%-831.73%-153.13%-50.80%-16.19%-158.08%
Upgrade
Buyback Yield / Dilution
-1503.64%-978.83%-37.51%-120.26%--
Upgrade
Updated Sep 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.